Chief Scientific Officer
Steve joined Teligent in October 2015 as our Chief Scientific Officer. In this role, he has primary responsibility for creating and executing the R&D strategy for the Company. Steve has almost 30 years of experience successfully leading the scientific functions of a number of companies in the generic and specialty pharmaceutical industry.
Prior to joining Teligent, Steve was Principal Consultant with Lachman Consultants, Inc., providing a wide array of scientific and business guidance to both pharmaceutical industry and financial investment clients. Prior to joining Lachman, Steve was with JHP Pharmaceuticals (now Endo International), Stiefel Laboratories (now GSK), Mayne Pharma (now Hospira) and Faulding Pharmaceutical.
Steve holds a BSc in Chemistry/Microbiology from the University of South Australia and an MBA from the University of Adelaide.